
- August 2012 Pain Awareness
- Volume 78
- Issue 8
Evaluation and Treatment of Patients with Major Depressive Disorder: Are We Considering All the Options?
This activity is supported by an educational grant from Mylan Specialty, LP.
Megan Maroney, PharmD
Clinical Assistant ProfessorErnest Mario School of PharmacyRutgers UniversityPiscataway, New JerseyClinical Psychiatric PharmacistMonmouth Medical CenterLong Branch, New Jersey
Megan Maroney, PharmD, has no financial relationships with commercial interests to disclose related to this activity.
Pharmacy Times Office of Continuing Professional Education Planning Staff
Judy V. Lum, MPA, Ann C. Lichti, CCMEP, and Elena Beyzarov, PharmD, have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.
Pharmacy Times Editorial Staff
Jennifer Whartenby and David Allikas have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.
The peer reviewer of this activity has no relevant financial relationships with commercial interests to disclose related to this activity.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
- Review the pathophysiology and epidemiology of major depressive disorder (MDD), atypical depression, and treatment-resistant depression.
- Address challenges of treating depression, including safety concerns (eg, adverse effects, drug—food interactions), noncompliance, relapse, and inadequate response to antidepressant therapy.
- Discuss current and emerging antidepressant treatments, including strategies used for typical and treatment-resistant depression.
- Formulate counseling strategies to improve patient outcomes in depression.
Target audience: Pharmacists
Type of activity: Knowledge
Release date: August 10, 2012
Expiration date: August 10, 2014
Estimated time to complete activity: 2 hours
Fee: This lesson is free online
Click
Articles in this issue
over 13 years ago
Legal Opioids: An Octopus of a Problemover 13 years ago
Rx Product Newsover 13 years ago
Case Studiesover 13 years ago
Effect of Telephonic Patient Support on Opioid Dependenceover 13 years ago
Smoking and Ovarian Cancer Riskover 13 years ago
Anxiety Disorders: Underdiagnosed and Undertreatedover 13 years ago
Medication Adherence: Taking Responsibilityover 13 years ago
Technology for AdherenceNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































